EPRX logo

EPRXEupraxia Pharmaceuticals Inc

$6.67
$0.195
(2.84%)
Today
Updated: 11:26 AM EDT
Mkt Cap$421.91M
Vol38,560.00
50

Neutral Sentiment

How do you feel about EPRX?

News
all
press releases
Eupraxia Pharmaceuticals' (EPRX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $11.00 price objective on shares of Eupraxia Pharmaceuticals in a research report on Monday...
MarketBeat
News Placeholder
More News
News Placeholder
Eupraxia Pharmaceuticals (EPRX) to Release Quarterly Earnings on Wednesday
Eupraxia Pharmaceuticals (NASDAQ:EPRX) will be releasing earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
News Placeholder
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Average Recommendation of "Moderate Buy" by Analysts
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight brokerages that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have given a buy re...
MarketBeat
News Placeholder
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Receives Buy Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $11.00 target price on shares of Eupraxia Pharmaceuticals in a report on Wednesday...
MarketBeat
News Placeholder
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Raised to "Sell" at Wall Street Zen
Wall Street Zen raised Eupraxia Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday...
MarketBeat
News Placeholder
New Strong Sell Stocks for April 2nd
ACCO, CDE and EPRX have been added to the Zacks Rank #5 (Strong Sell) List on April 2nd, 2026.
Zacks
News Placeholder
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 26.3% in March
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 13th, there was short interest totaling 2,500,950 shares, an increase of 26.3% from the February 26th total of 1,979,996 shares. Approximately...
MarketBeat
News Placeholder
Eupraxia Pharmaceuticals (EPRX) to Release Earnings on Tuesday
Eupraxia Pharmaceuticals (NASDAQ:EPRX) will be releasing earnings before the market opens on Tuesday, March 31. (View Earnings Report at...
MarketBeat
News Placeholder
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.read more...
Benzinga
News Placeholder
William Blair Initiates Coverage on Eupraxia Pharmaceuticals (NASDAQ:EPRX)
William Blair assumed coverage on shares of Eupraxia Pharmaceuticals in a report on Monday. They issued an "outperform" rating for the company...
MarketBeat
<
1
2
...
>